Cargando…
Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape
To limit the spread and impact of anti-malarial drug resistance and react accordingly, surveillance systems able to detect and track in real-time its emergence and spread need to be strengthened or in some places established. Currently, surveillance of anti-malarial drug resistance is done by any of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806256/ https://www.ncbi.nlm.nih.gov/pubmed/29422048 http://dx.doi.org/10.1186/s12936-018-2185-9 |
_version_ | 1783299090079023104 |
---|---|
author | Nsanzabana, Christian Djalle, Djibrine Guérin, Philippe J. Ménard, Didier González, Iveth J. |
author_facet | Nsanzabana, Christian Djalle, Djibrine Guérin, Philippe J. Ménard, Didier González, Iveth J. |
author_sort | Nsanzabana, Christian |
collection | PubMed |
description | To limit the spread and impact of anti-malarial drug resistance and react accordingly, surveillance systems able to detect and track in real-time its emergence and spread need to be strengthened or in some places established. Currently, surveillance of anti-malarial drug resistance is done by any of three approaches: (1) in vivo studies to assess the efficacy of drugs in patients; (2) in vitro/ex vivo studies to evaluate parasite susceptibility to the drugs; and/or (3) molecular assays to detect validated gene mutations and/or gene copy number changes that are associated with drug resistance. These methods are complementary, as they evaluate different aspects of resistance; however, standardization of methods, especially for in vitro/ex vivo and molecular techniques, is lacking. The World Health Organization has developed a standard protocol for evaluating the efficacy of anti-malarial drugs, which is used by National Malaria Control Programmes to conduct their therapeutic efficacy studies. Regional networks, such as the East African Network for Monitoring Antimalarial Treatment and the Amazon Network for the Surveillance of Antimalarial Drug Resistance, have been set up to strengthen regional capacities for monitoring anti-malarial drug resistance. The Worldwide Antimalarial Resistance Network has been established to collate and provide global spatial and temporal trends information on the efficacy of anti-malarial drugs and resistance. While exchange of information across endemic countries is essential for monitoring anti-malarial resistance, sustainable funding for the surveillance and networking activities remains challenging. The technology landscape for molecular assays is progressing quite rapidly, and easy-to-use and affordable new techniques are becoming available. They also offer the advantage of high throughput analysis from a simple blood spots obtained from a finger prick. New technologies combined with the strengthening of national reference laboratories in malaria-endemic countries through standardized protocols and training plus the availability of a proficiency testing programme, would contribute to the improvement and sustainability of anti-malarial resistance surveillance networks worldwide. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-018-2185-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5806256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58062562018-02-15 Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape Nsanzabana, Christian Djalle, Djibrine Guérin, Philippe J. Ménard, Didier González, Iveth J. Malar J Review To limit the spread and impact of anti-malarial drug resistance and react accordingly, surveillance systems able to detect and track in real-time its emergence and spread need to be strengthened or in some places established. Currently, surveillance of anti-malarial drug resistance is done by any of three approaches: (1) in vivo studies to assess the efficacy of drugs in patients; (2) in vitro/ex vivo studies to evaluate parasite susceptibility to the drugs; and/or (3) molecular assays to detect validated gene mutations and/or gene copy number changes that are associated with drug resistance. These methods are complementary, as they evaluate different aspects of resistance; however, standardization of methods, especially for in vitro/ex vivo and molecular techniques, is lacking. The World Health Organization has developed a standard protocol for evaluating the efficacy of anti-malarial drugs, which is used by National Malaria Control Programmes to conduct their therapeutic efficacy studies. Regional networks, such as the East African Network for Monitoring Antimalarial Treatment and the Amazon Network for the Surveillance of Antimalarial Drug Resistance, have been set up to strengthen regional capacities for monitoring anti-malarial drug resistance. The Worldwide Antimalarial Resistance Network has been established to collate and provide global spatial and temporal trends information on the efficacy of anti-malarial drugs and resistance. While exchange of information across endemic countries is essential for monitoring anti-malarial resistance, sustainable funding for the surveillance and networking activities remains challenging. The technology landscape for molecular assays is progressing quite rapidly, and easy-to-use and affordable new techniques are becoming available. They also offer the advantage of high throughput analysis from a simple blood spots obtained from a finger prick. New technologies combined with the strengthening of national reference laboratories in malaria-endemic countries through standardized protocols and training plus the availability of a proficiency testing programme, would contribute to the improvement and sustainability of anti-malarial resistance surveillance networks worldwide. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-018-2185-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-08 /pmc/articles/PMC5806256/ /pubmed/29422048 http://dx.doi.org/10.1186/s12936-018-2185-9 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Nsanzabana, Christian Djalle, Djibrine Guérin, Philippe J. Ménard, Didier González, Iveth J. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape |
title | Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape |
title_full | Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape |
title_fullStr | Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape |
title_full_unstemmed | Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape |
title_short | Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape |
title_sort | tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806256/ https://www.ncbi.nlm.nih.gov/pubmed/29422048 http://dx.doi.org/10.1186/s12936-018-2185-9 |
work_keys_str_mv | AT nsanzabanachristian toolsforsurveillanceofantimalarialdrugresistanceanassessmentofthecurrentlandscape AT djalledjibrine toolsforsurveillanceofantimalarialdrugresistanceanassessmentofthecurrentlandscape AT guerinphilippej toolsforsurveillanceofantimalarialdrugresistanceanassessmentofthecurrentlandscape AT menarddidier toolsforsurveillanceofantimalarialdrugresistanceanassessmentofthecurrentlandscape AT gonzalezivethj toolsforsurveillanceofantimalarialdrugresistanceanassessmentofthecurrentlandscape |